Zhou Juan, Soltow Marieke, Zimmermann Katrin, Pavlovic Dragan, Johnston Brent, Lehmann Christian
Department of Anesthesia, Dalhousie University, 5850 College St., Halifax, B3H 4R2 Nova Scotia, Canada; Department of Microbiology & Immunology, Dalhousie University, 5850 College St., Halifax, B3H 4R2 Nova Scotia, Canada.
Department of Anesthesia and Intensive Care Medicine, Ernst-Moritz-Arndt-University, Loefflerstr. 23, 17475 Greifswald, Germany.
Microvasc Res. 2015 Sep;101:33-7. doi: 10.1016/j.mvr.2015.06.004. Epub 2015 Jun 24.
Toll like receptor 4 (TLR4) represents a critical cellular link for endotoxin-induced pathology. The aim of this study was to evaluate the potential role of TLR4 inhibition on the intestinal microcirculation during experimental endotoxemia.
The intestinal microcirculation was studied by intravital microscopy in four groups of Lewis rats (n=10 per group): healthy controls (CON group), endotoxemic animals (15mg/kg lipopolysaccharide, LPS group), endotoxemic animals treated with a TLR4 antagonist (1mg/kg CRX-526, LPS+CRX526 group), and controls treated with CRX-526 (C-CRX526 group). Plasma samples were obtained for cytokine measurements at the end of the experiments.
Endotoxemia significantly increased leukocyte adhesion in intestinal submucosal venules (e.g., V1 venules: CON 20.4±6.5n/mm(2), LPS 237.5±36.2n/mm(2), p<0.05) and reduced capillary perfusion of the intestinal wall (e.g., longitudinal muscular layer: CON 112.5±5.9cm/cm(2), LPS 71.3±11.0cm/cm(2), p<0.05) at 2h. TLR4 inhibition significantly reduced endotoxemia-associated leukocyte adhesion (V1 venules: 104.3±7.8n/mm(2)) and improved capillary perfusion (longitudinal muscular layer: 111.0±12.3cm/cm(2)). Cytokine release was not significantly affected.
The TLR4 pathway may be a target in clinical Gram-negative sepsis since administration of the TLR4 antagonist CRX-526 improved intestinal microcirculation parameters in experimental endotoxemia.
Toll样受体4(TLR4)是内毒素诱导病理过程中的关键细胞连接。本研究旨在评估TLR4抑制在实验性内毒素血症期间对肠道微循环的潜在作用。
通过活体显微镜对四组Lewis大鼠(每组n = 10)的肠道微循环进行研究:健康对照组(CON组)、内毒素血症动物组(15mg/kg脂多糖,LPS组)、用TLR4拮抗剂治疗的内毒素血症动物组(1mg/kg CRX - 526,LPS + CRX526组)以及用CRX - 526治疗的对照组(C - CRX526组)。实验结束时采集血浆样本进行细胞因子测量。
内毒素血症显著增加了肠黏膜下小静脉中的白细胞黏附(例如,V1小静脉:CON组20.4±6.5个/n/mm(2),LPS组237.5±36.2个/n/mm(2),p<0.05),并在2小时时降低了肠壁的毛细血管灌注(例如,纵肌层:CON组112.5±5.9cm/cm(2),LPS组71.3±11.0cm/cm(2),p<0.05)。TLR4抑制显著降低了与内毒素血症相关的白细胞黏附(V1小静脉:104.3±7.8个/n/mm(2)),并改善了毛细血管灌注(纵肌层:111.0±12.3cm/cm(2))。细胞因子释放未受到显著影响。
由于TLR4拮抗剂CRX - 526给药改善了实验性内毒素血症中的肠道微循环参数,TLR4途径可能是临床革兰氏阴性脓毒症的一个治疗靶点。